Harrow and it’s affiliate Imprimis are focused on the development, production, sale, and distribution of innovative ophthalmic prescription medications that are accessible and affordable. These pharmaceutical products are used in the U.S. in ophthalmic surgical procedures, such as cataract and refractive surgeries, as well as large and growing chronic eyecare markets, such as dry eye disease, glaucoma, allergies, and infections. Harrow and Imprimis currently serve over 10,000 doctors, hospitals, and ambulatory service centers through an integrated national sales and customer service organization and an efficient, scalable, and tech-enabled national production and distribution platforms licensed to do business in all 50 U.S. states.
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot